Prognostic Significance of Selected Tumor Stroma Parameters in Patients with HER2-Positive Breast Cancer Treated with Adjuvant Trastuzumab
Aleksandra Ambicka(National Institute of Oncology), Agnieszka Adamczyk(National Institute of Oncology)
Cited by 0